Association of the calpain-10 gene with type 2 diabetes in Europeans: results of pooled and meta-analyses.
暂无分享,去创建一个
T. Hansen | O. Pedersen | L. Groop | M. Boehnke | T. Frayling | M. Weedon | A. Hattersley | M. Hanefeld | N. Cox | M. Orho-Melander | C. Dina | P. Froguel | M. Małecki | P. Schwarz | J. Graessler | T. Fingerlin | G. Bell | C. Hanis | Takafumi Tsuchiya | Julie C. Evans | L. Bosque-Plata | U. Julius | S. Fischer | J. Schulze | B. Bendlova | J. Vcelak | H. Rietzsch | T. Temelkova-Kurktschiev | D. Palyzová | M. Geoffrey Hayes | G. Wayne Towers | T. Selisko | G. Towers | N. Cox | M. Geo | J. Včelák | rey Hayes | T. Hansen | L. D. Bosque-Plata
[1] S. Gabriel,et al. Efficiency and power in genetic association studies , 2005, Nature Genetics.
[2] R. S. Spielman,et al. A genome–wide search for human non–insulin–dependent (type 2) diabetes genes reveals a major susceptibility locus on chromosome 2 , 1996, Nature Genetics.
[3] D. Moczulski,et al. Homozygous combination of calpain 10 gene haplotypes is associated with type 2 diabetes mellitus in a Polish population. , 2002, European journal of endocrinology.
[4] Kaisa Silander,et al. Variation in three single nucleotide polymorphisms in the calpain-10 gene not associated with type 2 diabetes in a large Finnish cohort. , 2002, Diabetes.
[5] Genetic variants in the calpain-10 gene and the development of type 2 diabetes in the Japanese population , 2005, Journal of Human Genetics.
[6] E S Lander,et al. The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. , 2000, Nature genetics.
[7] Ronnie Driver. Response to: 'Power dressing and meta-analysis: incorporating power analysis into meta-analysis' by S. Muncer (2002) Journal of Advanced Nursing 38, 274-280. , 2002, Journal of advanced nursing.
[8] C. Hanis,et al. Role of calpain-10 gene variants in familial type 2 diabetes in Caucasians. , 2002, The Journal of clinical endocrinology and metabolism.
[9] Eric S. Lander,et al. The common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes , 2000, Nature Genetics.
[10] Nancy J. Cox,et al. Loci on chromosomes 2 (NIDDM1) and 15 interact to increase susceptibility to diabetes in Mexican Americans , 1999, Nature Genetics.
[11] D. Hewett‐Emmett,et al. Origins of u.s. Hispanics: Implications for Diabetes , 1991, Diabetes Care.
[12] C. Lindgren,et al. Variants in the calpain-10 gene predispose to insulin resistance and elevated free fatty acid levels. , 2002, Diabetes.
[13] J. Akey,et al. Distribution of recombination crossovers and the origin of haplotype blocks: the interplay of population history, recombination, and mutation. , 2002, American journal of human genetics.
[14] M. Daly,et al. Haplotype structure and genotype-phenotype correlations of the sulfonylurea receptor and the islet ATP-sensitive potassium channel gene region. , 2004, Diabetes.
[15] Tom H. Lindner,et al. Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus , 2000, Nature Genetics.
[16] P. Donnelly,et al. A new statistical method for haplotype reconstruction from population data. , 2001, American journal of human genetics.
[17] S. Gabriel,et al. The Structure of Haplotype Blocks in the Human Genome , 2002, Science.
[18] M. McCarthy,et al. Making the right associations , 2005, Diabetologia.
[19] J. Manson,et al. Are variants in the CAPN10 gene related to risk of type 2 diabetes? A quantitative assessment of population and family-based association studies. , 2004, American journal of human genetics.
[20] Pak Chung Sham,et al. Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits , 2003, Bioinform..
[21] Peter Donnelly,et al. A comparison of bayesian methods for haplotype reconstruction from population genotype data. , 2003, American journal of human genetics.
[22] Shirley Taylor,et al. Power dressing and meta-analysis: incorporating power analysis into meta-analysis. , 2002, Journal of advanced nursing.
[23] T. Hansen,et al. Variants within the calpain-10 gene on chromosome 2q37 (NIDDM1) and relationships to type 2 diabetes, insulin resistance, and impaired acute insulin secretion among Scandinavian Caucasians. , 2002, Diabetes.
[24] N Risch,et al. Implications of multilocus inheritance for gene-disease association studies. , 2001, Theoretical population biology.
[25] R. Holle,et al. Meta-analysis and a large association study confirm a role for calpain-10 variation in type 2 diabetes susceptibility. , 2003, American journal of human genetics.
[26] Mark Daly,et al. Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..
[27] M. McCarthy,et al. Studies of association between the gene for calpain-10 and type 2 diabetes mellitus in the United Kingdom. , 2001, American journal of human genetics.
[28] Katrin Hoffmann,et al. Hidden population substructures in an apparently homogeneous population bias association studies , 2006, European Journal of Human Genetics.
[29] P. Tam. The International HapMap Consortium. The International HapMap Project (Co-PI of Hong Kong Centre which responsible for 2.5% of genome) , 2003 .
[30] E. Carlsson,et al. Genetic and nongenetic regulation of CAPN10 mRNA expression in skeletal muscle. , 2005, Diabetes.
[31] Nancy J Cox,et al. Patterns of linkage disequilibrium in the type 2 diabetes gene calpain-10. , 2005, Diabetes.
[32] Mark I McCarthy,et al. Progress in defining the molecular basis of type 2 diabetes mellitus through susceptibility-gene identification. , 2004, Human molecular genetics.